Bioventus Inc. Class A Common Stock (BVS) is a publicly traded Healthcare sector company. As of October 27, 2026, BVS trades at $14.71 with a market cap of $1.02B and a P/E ratio of 16.22. BVS moved -0.07% today. Year to date, BVS is +104.16%; over the trailing twelve months it is +112.10%. Its 52-week range spans $5.81 to $15.89. Analyst consensus is strong buy with an average price target of $17.50. Rallies surfaces BVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bioventus Inc. Class A Common Stock (BVS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BVS moved -0.07% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $14.71 |
| Market Cap | $1.02B |
| P/E Ratio | 16.22 |
| EPS | $0.81 |
| Dividend Yield | 0.61% |
| 52-Week High | $15.89 |
| 52-Week Low | $5.81 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $581.85M |
| Net Income | $61.48M |
| Gross Margin | 68.65% |
4 analysts cover BVS: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.50.